|
1
|
A cholinergic-adrenergic hypothesis of mania and depression.
|
Lancet
|
1972
|
1.97
|
|
2
|
Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.
|
Arch Gen Psychiatry
|
1973
|
1.11
|
|
3
|
Chlorpromazine: effects of antacids on its gastrointestinal absorption.
|
J Clin Pharmacol
|
1973
|
0.99
|
|
4
|
Cholinergic reversal of manic symptoms.
|
Lancet
|
1972
|
0.91
|
|
5
|
Amantadine hydrochloride treatment of tardive dyskinesia.
|
N Engl J Med
|
1971
|
0.83
|
|
6
|
Antagonistic effects of physostigmine and methylphenidate in man.
|
Am J Psychiatry
|
1973
|
0.83
|
|
7
|
Parasympathetic suppression of manic symptoms by physostigmine.
|
Arch Gen Psychiatry
|
1973
|
0.81
|
|
8
|
Effects of amantadine on tardive dyskinesia and pseudo-parkinsonism.
|
N Engl J Med
|
1972
|
0.77
|
|
9
|
Cholinergic antagonism of methylphenidate-induced stereotyped behavior.
|
Psychopharmacologia
|
1972
|
0.76
|
|
10
|
Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.
|
Am J Psychiatry
|
1973
|
0.76
|
|
11
|
The pharmacokinetics of butaperazine in serum.
|
Adv Biochem Psychopharmacol
|
1974
|
0.75
|
|
12
|
Reversal of benztropine toxicity by physostigmine.
|
JAMA
|
1972
|
0.75
|
|
13
|
Correlation between brain levels and biochemical effects of the optical isomers of p-chloroamphetamine.
|
J Pharmacol Exp Ther
|
1975
|
0.75
|